SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2752)4/9/2010 12:16:45 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
PURE continues on the uptrend that started on Tuesday and it seems that it doesn't want to close Wednesday's big UG.<g>

The stock is still up 9.6% with volume> 2M

bigcharts.marketwatch.com

PURE announced on Tuesday that it has received EPA registration for its SDC-based disinfectant and food contact surface sanitizer.<g>
The product provides an advantageous combination of high efficacy, low toxicity and efficiency by rapidly eliminating dangerous pathogens, yet no rinse is required.
It had received a patent for the product back in Oct.

PURE has 2Qs of better revenues, and was able to cut some its loss on the last Q. It has no significant LTD, but negative CF.
The ACTAY is $8 but I will keep my target at $4 <g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2752)4/10/2010 12:19:42 AM
From: Dave O.  Read Replies (1) | Respond to of 3722
 
Bought in the upper $1's. Sold low $3's. For the longs I hope it goes higher. I'll take a 50+% gain any day.



To: Jibacoa who wrote (2752)6/9/2010 2:59:04 PM
From: Jibacoa1 Recommendation  Read Replies (2) | Respond to of 3722
 
AVNR was up 16.66% at its intraday H and is still up 12.16% with volume > 1,616,100 > its ADV

The stock opened with an UG, apparently helped by its presentation at the Jefferies Meeting in N.Y. yesterday.<g>

bigcharts.marketwatch.com

The ACTAY is $7.97
But I will still keep my target at $4 <g>

bigcharts.marketwatch.com

Bernard